Moderna Crashes 21%. 'No Inflection In Sight' After Guidance Cut, CMV Shortfall.
Moderna stock crashed Monday after the firm slashed its outlooks for 2024 and 2025, and announced an expanded cost-cutting initiative. The post Moderna Crashes 21%. 'No Inflection In Sight' After Guidance Cut, CMV Shortfall. appeared first on Investor's Business Daily.
Moderna stock crashed Monday after the firm slashed its outlooks for 2024 and 2025, and announced an expanded cost-cutting initiative.
The post Moderna Crashes 21%. 'No Inflection In Sight' After Guidance Cut, CMV Shortfall. appeared first on Investor's Business Daily.
iShook Opinion
"iShook Opinion" by Beni E Rachmanov, CEO & Founder of iShook. Explore captivating perspectives on entertainment, lifestyle, and sports at ishookdaily.com. Your go-to for engaging insights.
